We have a strong history of partnering with other pharmaceutical companies, nonprofit organizations, government agencies, policymakers, trade associations and alliances, industry researchers and patient advocacy groups. In fact, in 2019, we collaborated with more than 60 associations worldwide on global public health issues. Below, explore a few examples of our key collaborations focused on access to medicine; public awareness and disease screening; and healthcare provider education and support.
We also strategically partner with other pharmaceutical companies to bring medicines to market and meet patient needs. Many of our noteworthy collaborations especially benefit low- and middle-income countries.
Some of our key industry partners include:
- Atomo Diagnostics
- Lupin Pharmaceuticals
- Mapi Pharma Ltd.
- Theravance Biopharma
- Fujifilm Kyowa Kirin Biologics